221 related articles for article (PubMed ID: 21170352)
21. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
22. Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery.
Shin SB; Cho HY; Kim DD; Choi HG; Lee YB
Eur J Pharm Biopharm; 2010 Feb; 74(2):164-71. PubMed ID: 19703559
[TBL] [Abstract][Full Text] [Related]
23. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
24. Engineered nanomedicine for myeloma and bone microenvironment targeting.
Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
[TBL] [Abstract][Full Text] [Related]
25. The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug.
Zhang X; Zeng X; Liang X; Yang Y; Li X; Chen H; Huang L; Mei L; Feng SS
Biomaterials; 2014 Nov; 35(33):9144-54. PubMed ID: 25109439
[TBL] [Abstract][Full Text] [Related]
26. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
Senthilkumar M; Mishra P; Jain NK
J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
[TBL] [Abstract][Full Text] [Related]
27. GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment.
Du Y; Zhang Q; Jing L; Liang X; Chi C; Li Y; Yang X; Dai Z; Tian J
Int J Nanomedicine; 2015; 10():3791-802. PubMed ID: 26060399
[TBL] [Abstract][Full Text] [Related]
28. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Derakhshandeh K; Soheili M; Dadashzadeh S; Saghiri R
Int J Nanomedicine; 2010 Aug; 5():463-71. PubMed ID: 20957168
[TBL] [Abstract][Full Text] [Related]
29. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery.
Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L
Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647
[TBL] [Abstract][Full Text] [Related]
30. Immune activity and biodistribution of polypeptide K237 and folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles radiolabeled with 99mTc.
He Z; Zhang X; Huang J; Wu Y; Huang X; Chen J; Xia J; Jiang H; Ma J; Wu J
Oncotarget; 2016 Nov; 7(47):76635-76646. PubMed ID: 27791199
[TBL] [Abstract][Full Text] [Related]
31. In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles.
Mattheolabakis G; Taoufik E; Haralambous S; Roberts ML; Avgoustakis K
Eur J Pharm Biopharm; 2009 Feb; 71(2):190-5. PubMed ID: 18929649
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
33. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
Luo G; Yu X; Jin C; Yang F; Fu D; Long J; Xu J; Zhan C; Lu W
Int J Pharm; 2010 Jan; 385(1-2):150-6. PubMed ID: 19825404
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy.
Liang PC; Chen YC; Chiang CF; Mo LR; Wei SY; Hsieh WY; Lin WL
Int J Nanomedicine; 2016; 11():2021-37. PubMed ID: 27274233
[TBL] [Abstract][Full Text] [Related]
35. Theranostic vesicles based on bovine serum albumin and poly(ethylene glycol)-block-poly(L-lactic-co-glycolic acid) for magnetic resonance imaging and anticancer drug delivery.
Liu Q; Zhu H; Qin J; Dong H; Du J
Biomacromolecules; 2014 May; 15(5):1586-92. PubMed ID: 24690007
[TBL] [Abstract][Full Text] [Related]
36. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and characterization of MeO-PEG-PLGA-PEG-OMe copolymers as drug carriers and their degradation behavior in vitro.
Duan Y; Zhang Y; Gong T; Zhang Z
J Mater Sci Mater Med; 2007 Oct; 18(10):2067-73. PubMed ID: 17558481
[TBL] [Abstract][Full Text] [Related]
38. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
Katsikogianni G; Avgoustakis K
J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
[TBL] [Abstract][Full Text] [Related]
39. Injectable thermosensitive PLGA-PEG-PLGA triblock copolymers-based hydrogels as carriers for interleukin-2.
Qiao M; Chen D; Hao T; Zhao X; Hu H; Ma X
Pharmazie; 2008 Jan; 63(1):27-30. PubMed ID: 18271299
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]